There isonly modest evidence for increased glucagon secretion in CF and CFRD patients.26 Rather, the only established secretion abnormality is failedcounter-regulatory secretion of glucagon in late phases of OGTT trials, eventhough there may be some aberrant increased secretion in the earlyphase.20,21,30. The gene discussed is GCG; the disease is cystic fibrosis.